Correlation Engine 2.0
Clear Search sequence regions

Sizes of these terms reflect their relevance to your search.

The widespread use of smartphones and the internet has enabled self-monitoring and more hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, including in the heterogenous and often vulnerable group of patients with interstitial lung diseases (ILDs). Home monitoring in ILD has the potential to improve access to specialist care, reduce the burden on health-care systems, improve quality of life for patients, identify acute and chronic disease worsening, guide treatment decisions, and simplify clinical trials. Home spirometry has been used in ILD for several years and studies with other devices (such as pulse oximeters, activity trackers, and cough monitors) have emerged. At the same time, challenges have surfaced, including technical, analytical, and implementational issues. In this Series paper, we provide an overview of experiences with home monitoring in ILD, address the challenges and limitations for both care and research, and provide future perspectives. VIDEO ABSTRACT. Copyright © 2023 Elsevier Ltd. All rights reserved.


Marlies S Wijsenbeek, Catharina C Moor, Kerri A Johannson, Peter D Jackson, Yet H Khor, Yasuhiro Kondoh, Sujeet K Rajan, Gabriela C Tabaj, Brenda E Varela, Pieter van der Wal, Richard N van Zyl-Smit, Michael Kreuter, Toby M Maher. Home monitoring in interstitial lung diseases. The Lancet. Respiratory medicine. 2023 Jan;11(1):97-110

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 36206780

View Full Text